<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36947">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02056821</url>
  </required_header>
  <id_info>
    <org_study_id>A20030</org_study_id>
    <nct_id>NCT02056821</nct_id>
  </id_info>
  <brief_title>Hemodynamic Effects on Cerebral Autoregulation in Acute Stroke</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Henry Ford Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates if there are hemodynamic alterations in acute stroke that predispose
      patients to impaired perfusion and regulation of cerebral blood flow. To test this, we will
      target recruitment of acute ischemic stroke patients who present to the ED within 12 hours
      of symptoms onset. Enrolled subjects will receive continuous noninvasive hemodynamic
      monitoring contemporaneous with measurements of cerebral blood flow velocities and cerebral
      oximetry.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in cerebral blood flow velocities</measure>
    <time_frame>initial 24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cerebral flow velocities determined by bilateral MCA measurements by TCD</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <condition>Ischemic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Acute (&lt; 12 hours) ischemic stroke patients presenting to the Emergency Department
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected ischemic stroke within 12 hours of symptom onset

          -  NIHSS â‰¥ 4

          -  Age 18 to 90 years

        Exclusion Criteria:

          -  Baseline modified Rankin Scale &gt; 3

          -  Pregnancy

          -  Intracranial hemorrhage on head CT

          -  Mechanical ventilation prior to enrollment

          -  Inadequate temporal windows for TCD analysis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joseph Miller, MD</last_name>
    <phone>313-916-5419</phone>
    <email>jmiller6@hfhs.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Miller, MD</last_name>
      <email>jmiller6@hfhs.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>February 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Joseph Miller, MD</investigator_full_name>
    <investigator_title>Senior Staff</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>transcranial doppler</keyword>
  <keyword>cerebral blood flow</keyword>
  <keyword>cardiac output</keyword>
  <keyword>non-invasive hemodynamic monitoring</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
